![Robert Hayes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Robert Hayes served as the Executive Director & Chief Scientific Officer at PYC Therapeutics Ltd. from 2017 to 2018.
Prior to that, he was the Senior Director-Protein Engineering at Johnson & Johnson (Austrial) Pty Ltd. and the Biologics Head at Amgen Australia Pty Ltd. Hayes holds a doctorate degree from Imperial College London and a graduate degree from University College London.
Precedenti posizioni note di Robert Hayes
| Società | Posizione | Fine |
|---|---|---|
| PYC THERAPEUTICS LIMITED | Direttore Tecnico/Scientifico/R&S | 30/11/2018 |
Johnson & Johnson (Austrial) Pty Ltd. | Corporate Officer/Principal | - |
Amgen Australia Pty Ltd. | Corporate Officer/Principal | - |
Formazione di Robert Hayes
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
9
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PYC Therapeutics Ltd.
 PYC Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides discovery and development of peptide based therapeutic candidates | Health Technology |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amgen Australia Pty Ltd. | |
Johnson & Johnson (Austrial) Pty Ltd. |
